The U.S. Autism Treatment Market
The incidence of autism among American children has soared from 1 in 150 in 2000 to 1 in 45 today, and 2.1 million children and adults now live with autism. Yet, few therapies exist to treat this disease—just a few medications and ABA (applied behavioral analysis) programs. This is a fragmented $1.8 billion market comprised of for-profit and non-profit providers that serve autistic patients via brick & mortar centers and in-home therapy provided by therapists. Waiting lists are growing and only 36% of patients are estimated to have access to insurance coverage.
The report includes: dollar value & growth of the market from 2009 to a 2022 forecast, market structure, key metrics of treatment centers, definition of and the types of autism, typical therapies used, how ABA programs work, insurance coverage, patient demographics, analysis of the market for drugs to treat autism (Risperdal, Abilify, Ritalin), latest CDC research findings on autism, market growth factors, economic costs, and a ranking of the top treatment chains/no. of centers.
Contains 11 in-depth competitor profiles and revenues of the largest players in the field: Autism Speaks, UPMC, Centria Autism Services, The Center for Autism & Related Disorders, the May Institute, Butterfly Effects, Autism Learning Partners, Autism Spectrum Therapies, Chance Light Behavioral Health, and City Pro Group.
The report includes: dollar value & growth of the market from 2009 to a 2022 forecast, market structure, key metrics of treatment centers, definition of and the types of autism, typical therapies used, how ABA programs work, insurance coverage, patient demographics, analysis of the market for drugs to treat autism (Risperdal, Abilify, Ritalin), latest CDC research findings on autism, market growth factors, economic costs, and a ranking of the top treatment chains/no. of centers.
Contains 11 in-depth competitor profiles and revenues of the largest players in the field: Autism Speaks, UPMC, Centria Autism Services, The Center for Autism & Related Disorders, the May Institute, Butterfly Effects, Autism Learning Partners, Autism Spectrum Therapies, Chance Light Behavioral Health, and City Pro Group.
STUDY SCOPE & METHODOLOGY, SOURCES USED
NATURE OF THE FIELD & PATIENT DEMOGRAPHICS
Summary: Definition of Autism Spectrum Disorder, typical symptoms, incidence In the population
Types of treatments used
Non-profit vs. for-profit treatment centers
Latest CDC data on incidence of autism, increase since 2000,
Rapid increase in disease population set to boost the future market
Facts about autism and the scope of the disorder, by the Autism Society
Economic costs
Risk factors and characteristics
Table: No. of children with autism by: gender, race, living in a metro area
MARKET SIZE & GROWTH, MARKET SEGMENTS
Estimates of market size and growth by other research firms
Rationale for estimating market size: by no. of treatment centers, avg. revenues per center, no. of therapists, % of children age 3-17 with autism, avg. cost of treatment programs, etc. – available information & proxy indicators
Discussion of major drivers of the market
Discussion of insurance coverage
Growth factors
List of the top 9 multi-center treatment organizations: no. of centers, actual or estimated annual revenues
Table: Size of the U.S. autism treatment market: 2009-2022 forecast (programs, drugs, total)
Table: Size of the autism medications market: 2006-2016 (Risperdal, Ritalin, others)
Table: Incidence of autism, no. of children with autism vs. population: 2000, 2010, 2016
ABA TREATMENT PROGRAMS & COMPETITORS (APPLIED BEHAVIOR ANALYSIS)
Discussion of types of programs: center-based, community, in-home therapy
Key metrics (no. of adults and children with autism, avg. revenues per treatment center, avg. per therapist, percent of patients using medications, percent with access to insurance coverage, estd. market value)
In-depth description of how ABA programs work, types of therapy, controversies
Description of other therapies used (TEAACH, speech therapy, occupational therapy)
Discussion of obstacles with insurance coverage, Medicare, Medicaid, other major market issues
Chart/Map Insurance coverage for autism treatment, by state
COMPETITOR PROFILES (DESCRIPTIONS OF PROGRAM, NUMBER OF SITES AND THERAPISTS, SPECIALTIES, HEADQUARTERS ADDRESS, ESTIMATED/ACTUAL REVENUES, EXPENSES)
Autism Treatment Network (Autism Speaks)
Florida Autism Center
UPMC
Centria Autism Services
The Center for Autism & Related Disorders (CARD)
May Institute
Butterfly Effects
Autism Learning Partners
Autism Spectrum Therapies
ChanceLight Behavioral Health & Education
City Pro Group
THE MARKET FOR AUTISM MEDICATIONS
Summary & Discussion of the drugs currently used to treat behavioral and emotional problems of autistic children, including mood stabilizers, antipsychotics, stimulants
List of drug companies doing research and clinical trials
Risperdal: description and uses, side effects and problems, sales
Abilify: description and uses, side effects and problems, sales
Ritalin: description and uses, side effects and problems, sales
Market Size: estimates by Marketdata, actual sales by drug companies, emergence Of less costly generics as patents expire
Future Outlook and 2022 forecasts
Table: Estimated sales of autism drugs in the U.S. 2006-2016, 2022 forecast
REFERENCE DIRECTORY
Directory of autism research, treatment and education organizations, societies, Institutes, magazines, reports, special surveys, experts, other information sources
NATURE OF THE FIELD & PATIENT DEMOGRAPHICS
Summary: Definition of Autism Spectrum Disorder, typical symptoms, incidence In the population
Types of treatments used
Non-profit vs. for-profit treatment centers
Latest CDC data on incidence of autism, increase since 2000,
Rapid increase in disease population set to boost the future market
Facts about autism and the scope of the disorder, by the Autism Society
Economic costs
Risk factors and characteristics
Table: No. of children with autism by: gender, race, living in a metro area
MARKET SIZE & GROWTH, MARKET SEGMENTS
Estimates of market size and growth by other research firms
Rationale for estimating market size: by no. of treatment centers, avg. revenues per center, no. of therapists, % of children age 3-17 with autism, avg. cost of treatment programs, etc. – available information & proxy indicators
Discussion of major drivers of the market
Discussion of insurance coverage
Growth factors
List of the top 9 multi-center treatment organizations: no. of centers, actual or estimated annual revenues
Table: Size of the U.S. autism treatment market: 2009-2022 forecast (programs, drugs, total)
Table: Size of the autism medications market: 2006-2016 (Risperdal, Ritalin, others)
Table: Incidence of autism, no. of children with autism vs. population: 2000, 2010, 2016
ABA TREATMENT PROGRAMS & COMPETITORS (APPLIED BEHAVIOR ANALYSIS)
Discussion of types of programs: center-based, community, in-home therapy
Key metrics (no. of adults and children with autism, avg. revenues per treatment center, avg. per therapist, percent of patients using medications, percent with access to insurance coverage, estd. market value)
In-depth description of how ABA programs work, types of therapy, controversies
Description of other therapies used (TEAACH, speech therapy, occupational therapy)
Discussion of obstacles with insurance coverage, Medicare, Medicaid, other major market issues
Chart/Map Insurance coverage for autism treatment, by state
COMPETITOR PROFILES (DESCRIPTIONS OF PROGRAM, NUMBER OF SITES AND THERAPISTS, SPECIALTIES, HEADQUARTERS ADDRESS, ESTIMATED/ACTUAL REVENUES, EXPENSES)
Autism Treatment Network (Autism Speaks)
Florida Autism Center
UPMC
Centria Autism Services
The Center for Autism & Related Disorders (CARD)
May Institute
Butterfly Effects
Autism Learning Partners
Autism Spectrum Therapies
ChanceLight Behavioral Health & Education
City Pro Group
THE MARKET FOR AUTISM MEDICATIONS
Summary & Discussion of the drugs currently used to treat behavioral and emotional problems of autistic children, including mood stabilizers, antipsychotics, stimulants
List of drug companies doing research and clinical trials
Risperdal: description and uses, side effects and problems, sales
Abilify: description and uses, side effects and problems, sales
Ritalin: description and uses, side effects and problems, sales
Market Size: estimates by Marketdata, actual sales by drug companies, emergence Of less costly generics as patents expire
Future Outlook and 2022 forecasts
Table: Estimated sales of autism drugs in the U.S. 2006-2016, 2022 forecast
REFERENCE DIRECTORY
Directory of autism research, treatment and education organizations, societies, Institutes, magazines, reports, special surveys, experts, other information sources
